![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)
Updated Calendar of 12 Extreme Trades on Pending FDA Decisions
Bullish Bankers (May 22nd, 2009) Writes:
Below are 12 extreme FDA trades for 11 companies with market caps below $200M which have pending new drug product decisions or other meetings/milestones scheduled with the FDA that are expected to have a major impact on each of the underlying stock prices as the PDUFA decision dates approach and the decision is ultimately announced. A high risk/reward trading approach to consider for speculative traders is investing a small amount of money that you can afford to lose in a basket of stocks included in extreme FDA and Clinical Trial Calendar trades, which are highlighted in periodic articles at BioMedReports.com.
Hemispherx Biopharma [HEB: 1.36, -0.10 (-6.85%)]: Ampligen (Poly I: Poly C12U) NDA (three month PDUFA decision date delay was announced on 2/18/09 as additional data was submitted by HEB within three months of original decision date). Ampligen is an experimental treatment for chronic fatigue syndrome (which has no
...Acute Myeloid Leukemia, Anti-Infective Drugs Advisory Committee;, Arthritis, breakthrough cancer pain;, bullish bankers, C12U;, chronic fatigue syndrome;, clinical drug product;, colorectal cancer, Committee for Medicinal Products for Human Use, Depression, drug product;, DSCO Discovery Labs;, european commission, European Medicines Agency, European Union, Fda, Fentanyl;, Financial, Fusilev;, heart failure, HEB;, inflammation, insomnia, Labcorp, Lymphoma, Market Commentary, Meda Ab, medicinal products, Memorial Day, Mike Havrilla, nerve pain, neuralgia, pain, pneumonia, prevention of respiratory distress syndrome;, Qutenza(TM);, Qutenza;, Spectrum Pharmaceuticals Inc, treatment for chronic fatigue syndrome;, treatment of chronic heart failure, treatment of depression, Tse, United States, USD, VNP40101M;
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.